Cargando…

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model

The interaction of lymphoma cells with their microenvironment has an important role in disease pathogenesis and is being actively pursued therapeutically using immunomodulatory drugs, including immune checkpoint inhibitors. Diffuse large B-cell lymphoma (DLBCL) is an aggressive high-grade disease th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felce, Suet Ling, Anderson, Amanda P., Maguire, Shaun, Gascoyne, Duncan M., Armstrong, Richard N., Wong, Kah Keng, Li, Demin, Banham, Alison H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145990/ https://www.ncbi.nlm.nih.gov/pubmed/32309216 http://dx.doi.org/10.3389/fonc.2020.00448

Ejemplares similares

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
por: Wong, Kah Keng, et al.
Publicado: (2016)

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
por: Brown, P J, et al.
Publicado: (2016)

Targeted gene silencing in the nervous system with CRISPR-Cas13
por: Powell, Jackson E., et al.
Publicado: (2022)

CRISPR guides induce gene silencing in plants in the absence of Cas
por: Sharma, Veerendra Kumar, et al.
Publicado: (2022)

The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21(WAF1/CIP1) in 143B Osteosarcoma Cell Growth Arrest
por: Gascoyne, Duncan M., et al.
Publicado: (2015)

RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
por: Thakore, Pratiksha I., et al.
Publicado: (2018)

Programmable CRISPR interference for gene silencing using Cas13a in mosquitoes
por: Kulkarni, Aditi, et al.
Publicado: (2020)

Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells
por: Okada, Masahiro, et al.
Publicado: (2017)

CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens
por: Zhang, Yun-mu, et al.
Publicado: (2023)

Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
por: Gumerson, Jessica D., et al.
Publicado: (2021)

RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line
por: Felce, Suet Ling, et al.
Publicado: (2021)

Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP
por: Houghton, Benjamin C., et al.
Publicado: (2022)

Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements
por: Thakore, Pratiksha I., et al.
Publicado: (2015)

Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9
por: Shin, Jun Wan, et al.
Publicado: (2022)

In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity
por: Cai, Huiqiang, et al.
Publicado: (2022)

Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems
por: Mao, Yanfei, et al.
Publicado: (2018)

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017)

DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins
por: Ding, Li, et al.
Publicado: (2022)

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
por: Han, Hua Alexander, et al.
Publicado: (2020)

CRISPR Screen in Regulatory T Cells Reveals Modulators of Foxp3
por: Cortez, Jessica T., et al.
Publicado: (2020)

In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer
por: Rushworth, Linda K, et al.
Publicado: (2020)

Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201
por: Trenevska, Iva, et al.
Publicado: (2021)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

A ‘suicide’ CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans
por: Wang, Yu, et al.
Publicado: (2016)

MISSA 2.0: an updated synthetic biology toolbox for assembly of orthogonal CRISPR/Cas systems
por: Zhang, Hai-Yan, et al.
Publicado: (2017)

CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
por: Hao, Liangliang, et al.
Publicado: (2023)

CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Durable CRISPR-Based Epigenetic Silencing
por: Nakamura, Muneaki, et al.
Publicado: (2021)

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019)

Precise and efficient silencing of mutant Kras(G12D) by CRISPR-CasRx controls pancreatic cancer progression
por: Jiang, Wang, et al.
Publicado: (2020)

Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the AAVS1 locus as not an entirely safe harbour
por: Bhagwan, Jamie R., et al.
Publicado: (2020)

Special focus CRISPR-Cas
por: Marchfelder, Anita
Publicado: (2013)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

CRISPR-Cas in Streptococcus pyogenes
por: Le Rhun, Anaïs, et al.
Publicado: (2019)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

CRISPR-Cas-Integrated LAMP
por: Atçeken, Nazente, et al.
Publicado: (2022)

Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing
por: Tang, Xu, et al.
Publicado: (2019)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D
por: Gascoyne, Duncan M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1l0p256u8pca6g3ka4csicukqk